Rare diseases
Investigational molecules
Locations
Back to Greece21 clinical trials in Voula, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
GreeceA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GreeceTitle: Study of Sibeprenlimab Treatment for Adults with Sjögren's Disease Using Subcutaneous Injections
GreeceStudy on Flecainide and Ranolazine for Restoring Heart Rhythm in Patients with Recent Atrial Fibrillation
GreeceStudy of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation
GreeceStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
GreeceStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
GreeceStudy on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus
GreeceStudy on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma
GreeceThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on Sjögren's Syndrome and Systemic Lupus Erythematosus, evaluating new therapeutic approaches and treatment effectiveness.
Research aims to improve systemic manifestations and patient-reported symptoms in these conditions.
Innovative trials exploring treatments for atrial fibrillation and acute myocardial infarction, with emphasis on stroke prevention and emergency interventions.
Focus on developing safer and more effective treatments for cardiac conditions.
Advanced research in treating severe conditions including sepsis and candidemia, testing novel therapeutic approaches.
Investigations aim to improve survival rates and treatment outcomes in critical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
